Puthanmadhom Narayanan Susrutha, O'Brien Daniel R, Sharma Mayank, Smyrk Thomas C, Graham Rondell P, Grover Madhusudan, Bharucha Adil E
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.
Clin Gastroenterol Hepatol. 2022 May;20(5):1019-1028.e3. doi: 10.1016/j.cgh.2021.09.029. Epub 2021 Oct 2.
BACKGROUND & AIMS: In addition to gastric sensorimotor dysfunctions, functional dyspepsia (FD) is also variably associated with duodenal micro-inflammation and epithelial barrier dysfunction, the pathogenesis and clinical significance of which are unknown. Our hypothesis was that miRNAs and/or inflammation degrade epithelial barrier proteins, resulting in increased duodenal mucosal permeability in FD.
We compared the duodenal mucosal gene expression and miRNAs, in vivo permeability (lactulose-mannitol excretion between 0 and 60 and 60 and 120 minutes after saccharide ingestion), ex vivo assessments (transmucosal resistance, fluorescein isothiocyanate [FITC]-dextran flux, and basal ion transport), and duodenal histology (light and electron microscopy) in 40 patients with FD and 24 controls.
Compared with controls, the mRNA expression of several barrier proteins (zonula occludens-1, occludin, claudin-12, and E-cadherin) was modestly reduced (ie, a fold change of 0.8-0.85) in FD with increased expression of several miRNAs (eg, miR-142-3p and miR-144-3-p), which suppress these genes. The urinary lactulose excretion and the lactulose:mannitol ratio between 60 and 120 minutes were greater in FD than in controls (P < .05). The FITC-dextran flux, which reflects paracellular permeability, was inversely correlated (r = -0.32, P = .03) with transmucosal resistance and directly correlated (r = 0.4, P = .02) with lactulose:mannitol ratio. Other parameters (mucosal eosinophils, intraepithelial lymphocytes, and mast cells, transmucosal resistance, FITC-dextran flux, average intercellular distance, and proportion of dilated junctions) were not significantly different between groups.
In FD, there is a modest reduction in the expression of several duodenal epithelial barrier proteins, which may be secondary to up-regulation of regulatory miRNAs, and increased small intestinal permeability measured in vivo.
除胃感觉运动功能障碍外,功能性消化不良(FD)还与十二指肠微炎症和上皮屏障功能障碍存在不同程度的关联,其发病机制和临床意义尚不清楚。我们的假设是,微小RNA(miRNA)和/或炎症会降解上皮屏障蛋白,导致FD患者十二指肠黏膜通透性增加。
我们比较了40例FD患者和24例对照者的十二指肠黏膜基因表达和miRNA、体内通透性(摄入糖类后0至60分钟以及60至120分钟之间的乳果糖-甘露醇排泄量)、体外评估(跨黏膜电阻、异硫氰酸荧光素[FITC]-葡聚糖通量和基础离子转运)以及十二指肠组织学(光学和电子显微镜检查)。
与对照组相比,FD患者中几种屏障蛋白(紧密连接蛋白-1、闭合蛋白、Claudin-12和E-钙黏蛋白)的mRNA表达略有降低(即变化倍数为0.8 - 0.85),同时几种抑制这些基因的miRNA(如miR-142-3p和miR-144-3-p)表达增加。FD患者在60至120分钟之间的尿乳果糖排泄量以及乳果糖与甘露醇的比值高于对照组(P < 0.05)。反映细胞旁通透性的FITC-葡聚糖通量与跨黏膜电阻呈负相关(r = -0.32,P = 0.03),与乳果糖与甘露醇的比值呈正相关(r = 0.4,P = 0.02)。其他参数(黏膜嗜酸性粒细胞、上皮内淋巴细胞和肥大细胞、跨黏膜电阻、FITC-葡聚糖通量、平均细胞间距离以及扩张连接的比例)在两组之间无显著差异。
在FD患者中,几种十二指肠上皮屏障蛋白的表达略有降低,这可能是调节性miRNA上调的继发结果,并且体内测量显示小肠通透性增加。